Clinical Trials Browser

Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction × Clear all

NCT03045770 2017-02-07

mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA

Phase NA Unknown

Gastrointestinal

Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction

NCT03030937 2017-01-25

Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA

Phase 2 Unknown

Gastrointestinal

Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction